Introduction
Acute liver failure (ALF) develops in humans or experimental animals in consequence of viral infection or after ingestion of hepatotoxic drugs. While ALF in most instances presents multi-organ failure (Bernal et al., 2013; Lee, 2012 Lee, , 2013 , it is usually associated with neurological decline defined as hepatic encephalopathy (HE), with brain oedema being its major, often fatal complication (Blei, 2008; Gupta et al., 2017;  https://doi.org/10.1016/j.neuint.2018.05.007 Received 16 January 2018; Received in revised form 11 May 2018; Accepted 13 May 2018 McCormick et al., 2003) . It is generally acknowledged that ALF-induced oedema is mainly cytotoxic in nature, resulting from water movement to the intracellular (predominantly intra-astrocytic) compartment, with moderate contribution of interstitial or vasogenic oedema (Chavarria et al., 2010; Scott et al., 2013) . Acute toxic liver failure (ATLF) evoked by exposure of mice to azoxymethane (AOM) relatively faithfully models drug-induced ALF and symptoms of acute human HE. These include (i) reproducible development of four stages of neurological decline, (ii) increased levels of ammonia in the blood and in the brain, (iii) altered brain amino acids profile, (iv) severe neurological dysfunctions (Belanger et al., 2006; Matkowskyj et al., 1999; McMillin et al., 2014; Popek et al., 2017) and (v) brain oedema (Belanger et al., 2006; Chastre et al., 2014; Nguyen et al., 2006; Rangroo et al., 2012) . The principal question of the present study was whether and in what degree brain oedema accompanying ATLF is associated with altered ion composition and pH of the interstitial space, parameters reflecting the ability of the brain to cope with pathophysiological consequences of cerebral fluid imbalance. To our knowledge, this problem has so far escaped analysis in the context of ATLF; only two studies known to us have dealt with potassium homeostasis in severe hyperammonemia, a condition not equivalent to ATLF (Rangroo et al., 2013; Sugimoto et al., 1997) .
In this study we first analysed the nature of brain oedema in AOM -treated mice in which neurological HE symptoms progressed to the pre-comatose stage III (Matkowskyj et al., 1999; Popek et al., 2017) . The MRI analysis revealed a decrease of the apparent diffusion coefficient (ADC), which is interpreted to define oedema as primarily cytotoxic (Chavarria and Cordoba, 2015) . Subsequently, we confirmed leaky blood-brain barrier indicative of a vasogenic component, and found increased retention of an intracisternally administered fluorescent marker, indicating impairment of a paravascular cerebrospinal fluid (CSF)/interstitial fluid (ISF) flow, termed glymphatic system (Iliff et al., 2012 
Materials and methods

Azoxymethane (AOM) model of ALF
Experiments were performed on 10-12 weeks old male C57Bl mice, with approval and under surveillance of the IV th Local Ethical Committee, National Drug Institute, Warsaw or of the University Committee on Animal Resources, University of Rochester Medical Center. ATLF was induced according to the protocol described in Popek et al. (2017) . Mice received a single intraperitoneal (i.p.) injection of 100 μg/g azoxymethane (AOM) (Sigma-Aldrich). Hypothermia in AOMinjected animals was prevented/corrected by using the heating pads exactly as described by Belanger et al. (2006) . Two i.p. injections (at 8 and 16 h post-AOM) of 5% glucose in saline (500μl volume) were given to prevent both dehydration and hypoglycaemia. All brain tissue analyses were performed 18-22 h after AOM administration, i.e. in the period in which by neurological criteria the animals were in the precomatous stage. Biochemical analyses performed at 20 h post-AOM showed increased serum concentrations of inflammatory cytokines (IL-6 and TNFα increased by 21 and 4.7 fold, respectively), blood ammonia (a 2.7-fold rise), and activity of liver damage marker enzymes: ALT (a 12-fold rise) and AST (a 4.7-fold rise) (Popek et al., 2017) .
Determination of apparent diffusion coefficient (ADC)
Brains of control and AOM-treated animals were scanned with Bruker BioSpec 70/30 Advance III system working at 7T, with a transmit cylindrical radiofrequency coil (8.6 cm inner diameter) and a mouse brain dedicated receive-only array coil (2 × 2 elements) positioned over the animal's head. The animals were positioned prone with the head placed in the stereotactic apparatus and anaesthesia mask, and were anesthetized at around 1.5-2% isoflurane in a mixture of oxygen and air. Respiration was monitored throughout the experiment. Structural transverse MR images covering the whole brain were acquired with T2-weighted TurboRARE (TR/TE = 6000/30 ms, RARE factor = 4, spatial resolution = 78 μm × 78 μm x 500 μm, 35 slices, no gaps, number of averages (NA) = 4, scan time = 25min). Spin echo diffusion-weighted images covering the whole brain were acquired (TR/TE = 7000/27 ms, b-values = 0, 600, 1110 s/mm 2 , number of directions = 1, spatial resolution = 156 μm × 156 μm x 700 μm, 25 slices, no gaps, scan time = 33 min). ADC maps were calculated using Bruker ParaVision 5.1 software. Atlas of each individual brain structure was obtained by automatically labelling whole brain using MRM NeAt atlas and transformation matrix (obtained in the normalization step). That automatic labelling algorithm was implemented as custom-made MATLAB script (http://www.mathworks.com/products/matlab/) exploiting modified functions provided by IBASPM software (http:// www.thomaskoenig.ch/Lester/ibaspm.htm). At the top of the analysis, ADC maps were overlaid with the corresponding individual brain structure atlas and mean ADC values from each structure voxels were calculated using custom-made MATLAB scripts.
Evans blue extravasation measurement
The Evans Blue (EB) (4 ml/kg in saline) was injected intravenously and allowed to circulate for 2 h. Mice were then perfused transcardially under anaesthesia with heparinised saline until perfusion fluid in effluent became colourless. Tissue samples (cortex and hippocampus) were extracted and weighed, homogenized in 50% trichloracetic acid and centrifuged at 4°C. Supernatant absorbance was measured spectrophotometrically at 620 nm (FLUOstar Omega microplate reader). Results were quantified using a standard curve.
Extracellular potassium ([K + ] e ) and pH measurements with ionsensitive microelectrodes in awake animals
The animals were anesthetised using isoflurane (2.5% in air), a 3 mm cranial window was prepared over somatosensory cortex, and dura mater was removed. The exposed scull was submerged in ACSF with 3 mM KCl. During the experiment lasting ∼2 h, awake but restrained mice were resting on heated pads to maintain body temperature at 37°C.
In vivo recordings were obtained from somatosensory cortex (200 μm below the exposed pial surface). Ion-sensitive microelectrodes (ISE) for K + , and H + were pulled from single-barreled pipette glass, salinised and loaded with a ∼300 μm column of valinomycin-based K + ion exchange resin (Potassium Ionophore I-Cocktail B, Sigma-Aldrich), or H + ion exchange resin (Hydrogen Ionophore I-Cocktail A, SigmaAldrich) and backfilled with 150 mM KCl or PBS with a pH of 7.4, respectively. A reference electrode was backfilled with 150 mM NaCl. The ISEs were calibrated before and following the K + /H + recording using aCSF solutions with a stepwise K + or H + gradient. The extracellular ion concentrations data were sampled at 10 kHz and filtered from 0.1 to 2 kHz using an MultiClamp 700A/700B, digitized using Digidata 1322A, recorded using Clampex 9.2 and analysed using Clampfit 10.2 (Ding et al., 2016) . The surgery for insertion of the microelectrode used for K + and pH recording was carried out within the 20th hour post AOM. First 15 min of recording served to equilibrate the system ("equilibration recording", Fig. 2A , inset) and the results from this period were not included. The results obtained during the next 1 h of recording ("genuine recording", Fig. 2A , inset) were averaged.
Brain microdialysis in freely moving mice
Mice were anesthetised with isoflurane (3.5% in air, and two 1.2-mm-diameter holes were drilled in the head, first at atlas coordinates AP −0.5, ML +0.5, and second at coordinates AP +2.0, ML −0.5, DV −0.5, in which skull screw and guide cannula were inserted, respectively. Guide cannula was implanted at 0.5 mm depth.
Before arousal, antibiotic (Baytril, 2.5%; 0.2 ml/kg b.w.) and a painkiller (Ketonal, 2.5 mg/kg b.w.) were subcutaneously administered. Animals were placed in 21-cm-diameter cylindrical cages with ad libitum access to food and water. One day after surgery, mice were anesthetised with isoflurane (3.5% in air) and a probe was implanted (CMA Microdialysis AB). The probe's diameter was 0.5 mm, the membrane length 2 mm, and the permeability of the probe's membrane was 20 kDa.
Brain was superfused with aCSF of the following composition (in mM): NaCl 130, KCl 5, CaCl 2 2.5, MgSO 4 1.3, KH 2 PO 4 1.25, NaHCO 3 26, and D-glucose 10, aerated with a mixture of 95% O 2 and 5% CO 2 . Microdialysis (aCSF flow rate: 2.5 μl/min) was commenced before AOM administration. Microdialysate obtained during the first 60 min was discarded. Subsequently, six microdialysate fractions (100μl samples) were collected every 40 min, and recordings made in the first fraction were used as a control. Then, the aCSF flow was slowed down to 0.2 μl/ min (with the probe remaining in place) and AOM was administered. After 16 h the original flow rate of 2.5 μl/min was restored and collection of microdialysate was restarted. The last full fraction collected between hour 18 and 22 was used for measurements of K + , Na + and lactate. All samples were immediately frozen at −80°C.
Photometric determination of extracellular sodium ([Na
Concentration of sodium and potassium ions in microdialysates from brain cortex was performed using flame photometer (PFP7, Jenway) (Kuczeriszka et al., 2013) . Results were quantified using a standard curve calculated from samples of known Na + /K + concentrations prepared in the Ringer solution.
Determination of extracellular lactate ([LAC] e )
Concentration of lactate in microdialysates from brain cortex was measured using a luminometric Lactate-Glo assay kit (Promega), according to the manufacturer protocol. The luminometry was measured with FLUOstar Omega microplate reader. Results were quantified using a standard curve.
Fluorescence tracer accumulation
To trace the exchange of CSF with ISF and thus assess the efficiency of fluid passage across the compartments, a fluorescent tracer was infused directly to the CSF. To inject the tracer, the animals were cannulated into the subarachnoid CSF of the cisterna magna. The surgery was performed under ketamine/xylasine anaesthesia 24 h prior to AOM or saline administration, to allow the animals to recover. Fluorescence tracer (BSA-conjugated Alexa 488; BSA MW ∼60 kDa) was infused by peristaltic pump at 2 μM/min rate for 5 min (10 μl total volume) to awake animals which 18-20 h earlier received saline or AOM. Dissected brains were drop-fixed in 4% paraformaldehyde 30 min post tracer injection, and the influx of the CSF tracer into the brain parenchyma was evaluated by whole-slice fluorescence microscopy (Olympus; Stereo Investigator Software). First, the 100 μm coronal slices of PFA fixed brains were cut on a vibratome and mounted on microscope glass slides with ProLong Gold Antifade Mountant (Thermo Fisher Scientific). Then, after manually setting identical threshold level for all slices of each individual brain, densitometric analysis of fluorescence in each slice was performed with ImageJ programme and calculated as a per cent of the total slice area (Iliff et al., 2014) . The total slice area was set as 100%, and the degree of tracer penetration was calculated as % of the total area. Next, mean tracer penetration value for all slices of a given brain was set as 100%.
Brain samples and slice preparation
The mice were anesthetised using gaseous Isoflurane, decapitated and after removal of meninges, the cerebral cortex was dissected. To obtain brain slices for the uptake experiments, the cortices were cut into 300 μM slices, using McIlwain tissue chopper.
2.10.
86
Rb uptake in cerebral cortical slices Uptake of radioactive rubidium ( 86 Rb) used as an analogue of K + was assayed using a modification of a procedure described in (Larsen et al., 2014 added. The uptake experiments were performed at 37°C for 5 min, the time point being established basing on a kinetic experiment (data not shown). The assay was terminated with three brief washes in ice-cold Krebs "stop" buffer containing 30 mM KCl and 50 μM BaCl 2 . The slices were weighed and put into vials with 2 ml of scintillation liquid (InstaGel). The radioactivity was determined with a Perkin Elmer scintillation counter.
Statistical analysis
The analysed data passed the Shapiro-Wilk test for normality and were expressed as the mean ± SD. Data were analysed with parametric tests, using the GraphPad Prism 6 software. p values < 0.05 were regarded as statistically significant.
Results
Water diffusion imaging by magnetic resonance spectroscopy disclosed a ∼10% decrease of ADC in AOM-treated mice (0.697 ± 0.034 and 0.626 ± 0.054 μm 2 /s in control and AOM-injected animals, respectively) (Fig. 1A) which is interpreted to reflect cytotoxic oedema (Chavarria and Cordoba, 2015) . Brains of AOM-treated mice accumulated significantly higher amount of intracisternally injected fluorescent CSF tracer than control brains (Fig. 1 B,C) , which indicates impaired para-vascular CSF passage. The paravascular level of the fluorescent CSF tracer in the brain parenchyma of mice with the AOM-induced HE was higher by 67.5% (264.5% ± 97.3) compared to control animals (157.9% ± 58.7) (Fig. 1 B,C) .
Massive accumulation (to ∼ 380% of control) of Evans Blue in brain of AOM-treated mice was observed (Fig. 1D ) (0.102 ± 0.11 and 0.386 ± 0.207 μg Evans Blue/g tissue in control and AOM-injected animals, respectively), confirming brain extravasation reported earlier in this model (Nguyen et al., 2006) and indicating possible contribution of vasogenic component to brain oedema.
Recordings of [K + ] e in cerebral cortex of control and AOM-treated mice in vivo, in awake animals with ion selective microelectrodes (ISE) ( Fig. 2A) , or in microdialysates, assessed photometrically (Fig. 2B) ] e ) were 146.8 ± 7.7 mM and 147 ± 6.5 mM in control and AOM-injected animals, respectively (Fig. 2D) (Fig. 2E) . The [pH] e recorded from the in vivo cerebral cortex with ISE, remained unaffected by AOM treatment (7.33 ± 0.07 vs. 7.29 ± 0.07) (Fig. 2F) .
Discussion
Evidence from NMR analysis of human pathology strongly suggests that ALF instigates HE with cytotoxic brain oedema, the contribution of vasogenic oedema being relatively minor (Bemeur et al., 2016; Scott et al., 2013) . In ATLF models in which ALF is induced by administration of drugs or other hepatotoxins, oedema has so far been documented by ultrastructural demonstration of profound astrocytic swelling (Dixit and Chang, 1990; Kato et al., 1992; Norenberg, 1977; Willard-Mack et al., 1996) and/or net gain in brain water content (Rangroo et al., 2012; Jayakumar et al., 2013) . In this study MRI analysis was carried out to provide quantitative data of water distribution in the AOM-affected brain. We concentrated on ADC, a parameter which allows to assess relative contribution of the cytotoxic and vasogenic component to the oedema. There is a consensus that human ALF of varying causes is associated with decreased ADC, which is interpreted to reflect domination of cytotoxic oedema over vasogenic oedema (Chavarria and Cordoba, 2015 , and references therein). Decreased ADC was also recorded in the liver devascularization ALF model in rat (Chavarria et al., 2010) . The here observed significant decrease of ADC in the AOM model (Fig. 1A) provides, to our knowledge for the first time, distinctive evidence for cytotoxic oedema in ATLF.
ATLF in the AOM model also caused increased intra-brain retention of a fluorescent tracer following its intracisternal administration (Fig. 1B) . Increased fluid accumulation in the interstitial space could contribute to interstitial brain oedema, as observed in human ALF patients (Rai et al., 2008) .
Intracisternally injected fluorescent tracer is thought to mark CSF passage in the glymphatic system, the recently described paravascular ISF/CSF exchange system (Iliff et al., 2012) . However, data gathered in this study are insufficient to predict whether AOM-induced fluorescent tracer retention reflected impairment of glymphatic flow or one or a few other mechanisms underlying the CSF flow (Hladky and Barrand, 2014) .
Irrespective of the underlying mechanism, fluid accumulation in the interstitial space has been suggested to contribute to the decrease of ADC in the brain tissue (Badaut et al., 2011; Thrane et al., 2014) .
While AOM administration causes EB extravasation indicating blood brain barrier leakage (Chastre et al., 2014; Nguyen et al., 2006 ; this study, Fig. 1B) , extravasation is limited to the nearest vicinity of the cerebral capillaries, with no evidence of its expansion to deeper regions of cortical parenchyma (Nguyen, 2010) . This limited blood-brain barrier (BBB) leakage in the AOM model is considered to be due to direct toxic effects of AOM or its metabolites at the barrier (Jayakumar et al., 2013) . Collectively, the above results can best be interpreted as reflecting contribution of cytotoxic and interstitial oedema to the intracerebral fluid imbalance in ATLF.
The principal finding of the present study is that neither [K + ] e and [Na + ] e , which directly reflect the brain ion homeostasis, nor pH e and
[Lac] e which characterize the acid-base balance are altered at the neurologically advanced stage of AOM-induced ATLF (Popek et al., 2017) which is associated with brain oedema. The resistance of ion homeostasis and proton-base homoeostasis in the development of HE and oedema deserves comment with regard to changes observed in the clinic cases and in other models of ALF and HE. ] e has been reported in the brains of rats with systemically induced hyperammonemia (Sugimoto et al., 1997) and in ornithine transcarbamylase -deficient mice following acute systemic or intracerebral administration of ammonium (Rangroo et al., 2013) . However, the above procedures increased blood ammonia to a much higher level than that observed in AOM-induced ALF (∼10 or 7-fold of the control level in hyperammonemia (Rangroo et al., 2013; Sugimoto et al., 1997) vs 2.5-fold in the AOM-induced ALF (Popek et al., 2017) . Moreover, in the study described in (Rangroo et al., 2013) astrocytic swelling was absent in hyperammonemic animals. The result confirms the now generally accepted view that HE associated with ALF develops in consequence of the toxic effects of ammonium in conjunction with the inflammatory response and contribution of other blood-derived toxins (Aldridge et al., 2015) . Otherwise this view is corroborated by earlier findings that hyperammonemia is not equivalent to HE associated with ALF in terms of metabolic responses of the brain Albrecht, 1991, 1993; Hilgier et al., 1991) .
The absence of difference in the 86 Rb uptake in brain slices derived from AOM-treated mice as compared to control mice (Fig. 2C ) adds credibility to, and provides mechanistic basis for the conclusion that Rb efflux was observed in primary rat astrocytes treated with 5 mM of ammonium (Obara-Michlewska et al., 2011) , in HEK 293 cells exposed to 10 mM of ammonium (Obara-Michlewska et al., 2010) . Decreased rubidium uptake was also reported for cultured mice astrocytes treated with 10 mM ammonia (Rangroo et al., 2013) . Increased brain tissue or extracellular lactate content has been recorded in brain of comatose human ALF patients (Bjerring et al., 2010; Tofteng et al., 2002) , of rats (Zwingmann et al., 2003) or guinea pigs in which ALF was induced by hepatic artery ligation (HAL) (Rose et al., 2007) , and in pigs with surgically resected liver (Prazak et al., 2013) . The above articles have uniformly interpreted elevation of whole brain lactate (or lactate/pyruvate ratio) in ALF as manifestation of brain energy metabolism, Tentatively, increased extracellular accumulation of lactate could, among other causes, be due to its impaired shuttle between astrocytes and neurons, where it serves as a critical fuel (reviewed by Pellerin and Magistretti, 2012) . Here we found that extracellular lactate does not change in the brains of ATLF-affected mice in the AOM (Fig. 2E) . This is in agreement with the lack of changes of whole brain tissue lactate measured in the same stage of the AOM model in situ using NMR spectroscopy (Popek et al., 2017) . More detailed analysis of brain energy status has not been the focus of the present study. However, extracellular lactate accumulation is also the lately identified marker of glymphatic dysfunction (Lundgaard et al., 2017) . In the AOM model, impaired interstitial fluid passage was not reflected by change in extracellular lactate and pH, indicating involvement of an as yet unidentified mechanism that counteracted the occurrence of interstitial acid/base imbalance.
In conclusion, the study shows that in the mouse AOM model, ATLF associated with cytotoxic brain oedema and interstitial fluid imbalance is not accompanied by discernible impairment of interstitial ion and acid-base homeostasis. It is well established that intra-astrocytic water accumulation responsible for cytotoxic brain oedema in HE is related to the impaired function of a heterogeneous set of ion and water channels, and metabolite-transporting molecules operating in astrocytes (Albrecht et al., 1985; Allert et al., 1998; Kala et al., 2000; LichterKonecki et al., 2008; Sugimoto et al., 1997) . The simplest interpretation of our observations is that in ALF induced by AOM, astrocytes suffered a "half-way" loss of homeostatic function: having lost the ability to maintain their own cell volume, they are still capable of controlling the extracellular ionic and acid-base balance of the brain. Adequate buffering of extracellular ions (unchanged interstitial pH/K + /Na + ) indicates the ability of the cells (astrocytes) to compensate for oedemainduced disturbances in ion trafficking. The compensatory response appears to be secured by the maintenance of undisturbed potassium transport, as reflected by unchanged ability of brain slices derived from AOM mice to take up 86 Rb. The status of the individual ion transporting moieties and their contribution to the maintenance of the ion balance will have to be established in separate studies. Such an efficient control of brain ionostasis may not occur when subacute toxic liver failure is induced by a prolonged (few day) exposure to a hepatotoxin (vide: the rat thioacetamide model; Faff-Michalak and FaffMichalak and Albrecht, 1993; Hilgier et al., 1991) , or when ALF is due to liver devascularization. It is tempting to speculate that interstitial ion and acid-base homeostasis is likewise relatively stable in human ALF cases in which hepatotoxic drug overdose is a causative factor. This would explain the relatively high incidence of spontaneous or treatment-supported neurophysiological recovery in this group of patients (Lee, 2012; Reddy et al., 2016) .
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